Have moderate-to-severe eczema? Participate in a research study to test an investigational medication
Center For Dermatology Clinical Research

Enter your info and the study team will contact you soon!
Your data is securely stored and only shared with the research team
Logo Image
"We're investigating whether an investigational medication is safe and effective for eczema"
Age: 18 - 75
Healthy Volunteers: No
Keywords: Atopic dermatitis, Eczema
Type: Phase 2, Drug Study
The goal of this study is to investigate the safety and efficacy of an investigation medication in eczema. The study medication is an antibody that acts against a protein that plays a role in the body's immune system.

Eczema, also known as Atopic Dermatitis, is a common skin condition that often affects people with a family history of allergies. It is characterized by dry, red, itchy, cracked or inflamed skin.

This study is conducted at the Center For Dermatology. Board Certified Dermatologists evaluate and oversee all research participants. You will receive all study medication, or placebo and study evaluations, and reimbursement for your time may be available.
This study requires

Participation in the study may last up to approximately 41 weeks with up to 15 visits to the study clinic.

Who can participate
  • Adults between the ages of 18 and 75
  • Have moderate-to-severe eczema

Other eligibility criteria will be determined during the initial clinic visit.

Who CANNOT Participate: - Pregnant or planning a pregnancy

Study duration and period
Up to 15 study visits over a 41 week period
Center For Dermatology Clinical Research
2557 Mowry Avenue
Suite 21
Fremont, CA 94538
Leanne Saud

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:

E-mail Preview